Record Details

Anti-diabetic nutraceutical from CMFRI soon The Hindu dated 16th May 2016

CMFRI Repository

View Archive Info
 
 
Field Value
 
Relation http://eprints.cmfri.org.in/10874/
 
Title Anti-diabetic nutraceutical from CMFRI soon The Hindu dated 16th May 2016
 
Creator CMFRI, Library
 
Subject Library & Information Science
CMFRI News Clippings
 
Description An anti-diabetic nutraceutical, Cadalmin, developed by Indian Council of Agriculture Research (ICAR)-
Central Marine Fisheries Research Institute (CMFRI), is expected to be available for the public soon.
Director, ICAR-CMFRI A. Gopalakrishnan, had recently signed a Memorandum of Understanding with
a Hyderabad-based company for commercial production and marketing of Cadalmin in Kochi. The
product is effective to combat type-2 diabetes, said a statement issued by the CMFRI here.
Cadalmin, which has 100 per cent natural marine bioactive ingredients from selected seaweeds, would
be made available in 500 mg capsules by the company.
The active ingredients in the product would be packed in plant-based capsules to meet the dietary needs
of the large vegetarian population in India and abroad.
The nutraceutical is prepared from seaweeds, which are commonly available in the Indian coastal
waters.
Seaweeds are the natural bounty of the sea and are known for their medicinal properties.
 
Publisher The Hindu
 
Date 2016-05-16
 
Type Other
NonPeerReviewed
 
Format text
 
Language en
 
Identifier http://eprints.cmfri.org.in/10874/1/The%20Hindu_16%20May_Antidiabetic%20nutraceutical.pdf
CMFRI, Library (2016) Anti-diabetic nutraceutical from CMFRI soon The Hindu dated 16th May 2016. The Hindu.